Artificial Intelligence in Drug Discovery Market Growth Accelerated by adoption of AI in Drug Discovery
Artificial Intelligence in Drug Discovery Market |
Artificial
intelligence (AI) has been increasingly adopted in drug discovery efforts to
identify and develop new drug candidates in a more efficient manner. AI tools
such as machine learning and deep learning are being used to screen large
chemical libraries, predict toxic side effects, design novel molecules with
desirable properties, and facilitate clinical trial recruitment and monitoring.
The global Artificial Intelligence in Drug Discovery Market is estimated to be
valued at US$ 1266.7 Mn in 2023 and is expected to exhibit a CAGR of 6.9% over
the forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
The increasing adoption of AI in drug discovery is mainly attributed to its
ability to analyze large and complex datasets and identify meaningful patterns
at a faster pace compared to human researchers. AI algorithms can screen
millions of potential drug compounds in silico and identify those with highest
probability of success based on properties like binding affinity, ADMET
profiles, and synthetic feasibility. This has significantly accelerated the
early drug discovery process by reducing the candidate pool for further
testing. AI is also being utilized for areas like predictive toxicology to enhance
safety assessment of new molecules in development. The technology is therefore
finding increasing investment and application in pharmaceutical R&D to
optimize efficiency and compress development timelines.
Segment
Analysis
The global artificial intelligence in drug discovery market is dominated by
fragment-based drug discovery sub-segment. This sub-segment is leading as AI
has the potential to screen millions of molecules much faster than traditional
computer-aided drug design. AI algorithms can virtually screen compound
libraries against biological targets, rank-order these compounds based on their
structural and activity predictions, and select the most promising candidates
for experimental validation.
Key Takeaways
The Global
Artificial Intelligence In Drug Discovery Market Share is expected to
witness high growth.
Regional
analysis: North America presently dominates the global market and is expected
to maintain its dominance over the forecast period. This is attributed to the
presence of major players and higher R&D expenditure on drug development in
the region.
Key players operating in the artificial intelligence in drug discovery market
are Lenzing A.G., Aditya Birla Group, AkzoNobel N.V., Smartfiber AG, Nien Foun
Fiber Co., Ltd., Invista , Baoding Swan Fiber Co. Ltd., Qingdao Textiles Group
Fiber Technology Co., Ltd., China Bambro Textile (Group) Co., Ltd., Acegreen
Eco-Material Technology Co. Ltd., China Populus Textile Ltd., and Acelon
Chemicals & Fiber Corp.
Explorer more information on this topic, Please visit
@ https://www.insightprobing.com/artificial-intelligence-in-drug-discovery-market-growth-demand/
Get
more insights on this topic: https://shoutingstars.com/pd-1-and-pd-l1-inhibitors-a-promising-cancer-immunotherapy
Comments
Post a Comment